Search clinical trials for: Tubes 3~5Tablet, QD

Total 270 results

LegoChem Biosciences, Inc

Completed

A Phase II Clinical Study of LCB01-0371 to Evaluate the EBA, Safety and PK

Pulmonary Tuberculosis

Korea, Republic of
GlaxoSmithKline

Completed

Efficacy and Safety Study in Subjects With Asthma

Asthma

United States
Pfizer

Terminated

Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations

Parkinson's Disease With Motor Fluctuations

United States
Pfizer

Terminated

Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations

Parkinson Disease

United States, Spain, Canada, France, Japan, Germany
Centre Hospitalier Universitaire Dijon

Completed

Study of the T CD8 Immune Response in Horton's Disease (Horton CD8)

Horton's Disease

France
Valenta Pharm JSC

Recruiting

Safety, Tolerability and Pharmacokinetics of 4-MUST, Tablets, 128 mg (Valenta Pharm JSC) During Single and Multiple Oral Administration in Healthy Volunteers

Cholecystitis

Russian Federation
Enteris BioPharma Inc.
Syneos Health; Parexel

Recruiting

Study to Evaluate the Pharmacodynamics and Efficacy of Leuprolide Tablets (Ovarest®) in Women With Endometriosis

Endometriosis

United States
Stallergenes Greer

Completed

Dose Ranging Study of SLIT Tablets of House Dust Mite Allergen Extracts (HDM) in Adults With HDM-associated Allergic Asthma

Asthma | House Dust Mite Allergy

France, Germany, Poland
Hartford Hospital
Spero Therapeutics

Completed

Bioavailability of Tebipenem (SPR994) Crushed Tablet

Relative Bioavailability

United States
Mylan Pharma UK Ltd.

Completed

Revefenacin in Chinese Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease(COPD)

COPD

China
Hansu Bae

Recruiting

Impact of Patient Position on the Success in Placing Triple-cuffed Double Lumen Endotracheal Tube

Lung Diseases

Korea, Republic of
Massachusetts General Hospital
BrainCells Inc.

Completed

Efficacy and Safety Study of a Combination Product [Drug:BCI-024 (Buspirone) and Drug:BCI-049 (Melatonin)] to Treat Major Depressive Disorder (MDD)

Major Depressive Disorder

United States
Bristol-Myers Squibb

Completed

Safety Study of INX-08189, Pharmacokinetic and Pharmacodynamic With Ribavirin and Food Effect Study, in Chronically-infected Genotype 1 Hepatitis C Virus, Treatment-naïve Subjects (INH-189-006)

Hepatitis C

United States, Puerto Rico
UCB Biopharma SRL

Withdrawn

A Study to Test the Blood Concentration of 4 Padsevonil Product Variants and the Effect of Food on Padsevonil

Epilepsy | Healthy Participants
University of Washington
National Institute of Allergy and Infectious Diseases (NIAID); Merck Sharp... and other collaborators

Terminated

RESIST-2: 2nd-line ART for HIV-2 Infection (RESIST-2)

HIV-2 Infection

Senegal
EMS

Withdrawn

Efficacy and Safety of Two Doses of Hipnos in the Treatment of Adults With Insomnia

Insomnia
Shanghai Pharmaceuticals Holding Co., Ltd
R&G Pharma Studies Co.,Ltd.

Completed

Safety and Efficacy of SPH3127 on Treating Mild-moderate Essential Hypertension Patients

Hypertension,Essential

China
Ohio State University
Vidatak, LLC

Completed

Vidatalk Communication Application: Usability, Acceptability and Efficacy Study

Critical Illness | Nonverbal Communication

United States
ViiV Healthcare
GlaxoSmithKline

Completed

A Study to Assess the Relative Bioavailability of Tablet Formulations of GSK2248761 in Healthy Adult Subjects. SGN114435

Infection, Human Immunodeficiency Virus | Infections, Human Immunodeficiency Virus and Herpesviridae

United States
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Unknown

A Phase II Study to Evaluate the Efficacy and the Safety of Flumatinib in CML-AP or CML-BP Patients

Chronic Myelogenous Leukemia

China
Bristol-Myers Squibb

Completed

Study to Evaluate the Pharmacokinetics and Safety of INX-08189 Administered With VictrelisTM in Healthy Subjects (INX-189-004)

Healthy

United States
AstraZeneca

Completed

A Study to Investigate How Common Pancreatic Exocrine Insufficiency (PEI) is in Patients With Type 2 Diabetes and Also to Investigate the Uptake of a Single Dose of EPANOVA® or OMACOR® in Patients With Different Degrees of PEI (PRECISE)

Diabetes Mellitus, Type 2 | Exocrine Pancreatic Insufficiency

Sweden, Poland, Latvia, Denmark, Hungary, Slovakia
Asieris Pharmaceuticals (AUS) Pty Ltd.

Completed

A Phase I, Two-phase, Crossover Study to Evaluate the Safety, Tolerability and Pharmacokinetics of APL-1501 ER Tablets

Bladder Cancer

Australia
Aragon Pharmaceuticals, Inc.

Completed

Bioavailability Study of 3 Tablet Formulations vs. Capsule Formulation of JNJ-56021927 in Fasting Healthy Male Participants

Healthy

United States
Mayo Clinic
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National... and other collaborators

Completed

Omega-3 Fatty Acids and Insulin Sensitivity

Insulin Resistance

United States
Haisco Pharmaceutical Group Co., Ltd.
The Fourth Hospital of Hebei Medical University

Recruiting

A Study Evaluating Drug-Drug Interaction (DDI) Between HSK16149 Capsules and Metformin Hydrochloride Tablets

Diabetic Neuropathies | Diabetic Neuropathy Peripheral

China
Boehringer Ingelheim
Eli Lilly and Company

Completed

Relative Bioavailability of 2 Fixed Dose Combinations of Empagliflozin/Metformin Extended Release (XR) Compared With Single Tablets

Healthy

United States
University of Edinburgh
NHS Lothian

Completed

The Effect Of Omega-3 Fatty Acids on Non-alcoholic Fatty Liver Disease

Non Alcoholic Fatty Liver Disease

United Kingdom
E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.

Not yet recruiting

A Study of QY201 Tablet in Subjects With Moderate to Severe Atopic Dermatitis

Atopic Dermatitis
GlaxoSmithKline

Completed

Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) 300mg in Chinese Subjects With Chronic Hepatitis B (CHB) (TDF in CHB)

Hepatitis B

China
University of Alberta

Withdrawn

Impact of Nutrition and Swallowing Function of Head and Neck Cancer Patients During the Course of Treatment

Head and Neck Cancer | Surgery | Nutrition | Swallowing

Canada
Rennes University Hospital

Completed

Investigation of Immunological and Pharmacological Factors for Response to Adalimumab in Rheumatoid Arthritis (PROMETHEE)

Rheumatoid Arthritis

France
Dr. Reddy's Laboratories Limited

Completed

A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)

Psoriasis

United States
Federal University of Health Science of Porto Alegre

Completed

The Effect of Nutritional Interventions on Exercise-induced Muscle Damage

Muscle Damage

Brazil
GlaxoSmithKline

Completed

Safety and Efficacy Study Adding GSK2190915 to Mid-dose Inhaled Corticosteroid/Long Acting Beta Agonist Combination Treatment for Asthma

Asthma

Bulgaria, Ukraine, Poland
Oslo University Hospital
Takeda Nycomed; Sykehuset Asker og Baerum

Completed

Does Oral Magnesium Substitution Relieve Pregnancy Induced Leg Cramps ?

Cramps
KalVista Pharmaceuticals, Ltd.

Completed

Phase 1 Crossover Study in Healthy Subjects to Evaluate the PK Profile of KVD824 Following Single and Multiple Doses of Modified Release (MR) Formulations

Hereditary Angioedema

United Kingdom
Hanlim Pharm. Co., Ltd.

Completed

A Clinical Trial to Evaluate Tolerability and Pharmacokinetics of HL217 Eye Drop in Healthy Male Subjects

Healthy Subject
Boehringer Ingelheim
Eli Lilly and Company

Completed

Relative Bioavailability of 2 Fixed Dose Combinations of Empagliflozin/Metformin Compared With Single Tablets

Healthy

United States
AstraZeneca
Parexel

Completed

A Study to Assess the Bioavailability of Different Formulations of AZD5718 and the Food Effect on the Selected Formulation of AZD5718 in Healthy Volunteers

Coronary Artery Disease

United Kingdom
Humanis Saglık Anonim Sirketi

Completed

Bioequivalence Study to Compare Two Tablets of Ivermectin Tablets (3 mg Ivermectin) Versus Two Tablets of Stromectol ® Tablets (3 mg Ivermectin), in Healthy Subjects Under Fasting Conditions

Anthelmintic Agent

Jordan
Enteris BioPharma Inc.
Syneos Health

Completed

A Study of Pharmacokinetic/Pharmacodynamic Profile of Orally Administered Leuprolide in Healthy Female Volunteers

Endometriosis

Canada
Peking Union Medical College Hospital
Chinese Academy of Sciences

Unknown

Response of Gut Microbiota in Type 2 Diabetes to Hypoglycemic Agents

Type2 Diabetes Mellitus

China
Portola Pharmaceuticals

Terminated

A Healthy Volunteer PK/PD, Safety and Tolerability Study of Andexanet After Betrixaban Dosing

Bleeding

United States
NYU Langone Health

Completed

Impact of Estrogen on Fear Extinction R61

Fear | Fear; Examination, Phobic

United States
Children's Mercy Hospital Kansas City

Completed

Thoracoscopy Versus Fibrinolysis in Children With Empyema

Empyema

United States
St. Louis University

Withdrawn

Insulin Resistance Following ADT for Prostate CA

Insulin Resistance | Prostate Cancer

United States
Gilead Sciences

Completed

GS-5885, GS-9451, Tegobuvir and Ribavirin (RBV) in Interferon Ineligible or Intolerant Subjects With Chronic Genotype 1a or 1b Hepatitis C Virus (HCV) Infection

Chronic Genotype 1a or 1b HCV Infection

United States, Canada, Puerto Rico
Brightlobe Limited

Recruiting

A Game-based Neurodevelopmental Assessment for Young Children (BRIGHTEN)

Neurodevelopmental Disorders | Autism Spectrum Disorder | Attention Deficit Hyperactivity Disorder | Dyslexia | Child Development | Specific Learning Disorder

United Kingdom
Cerevel Therapeutics, LLC

Recruiting

A Study Evaluating the Pharmacokinetics and Relative Bioavailability of Emraclidine Immediate-Release Tablets in Healthy Adult Participants

Healthy Participants

United States

3

Subscribe